RK
Rajamanikkam Kandasamy
About Rajamanikkam Kandasamy
Data last updated:
Rajamanikkam Kandasamy has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Biofloris Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biofloris Pharmaceuticals Private Limited at ₹5.84 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biofloris Pharmaceuticals Private Limited U33300TZ2017PTC029531 | Director | 01 Dec 2017 | 2017 | ₹5.84 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajamanikkam Kandasamy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajamanikkam Kandasamy
Rajamanikkam Kandasamy has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Biofloris Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biofloris Pharmaceuticals Private Limited at ₹5.84 Cr (FY 2025).
Rajamanikkam Kandasamy is associated with 1 company as Director, including Biofloris Pharmaceuticals Private Limited (₹5.84 Cr).
Rajamanikkam Kandasamy has expertise in General Business.
Rajamanikkam Kandasamy has 8 years in corporate governance.
By reported revenue, the largest current company of Rajamanikkam Kandasamy is Biofloris Pharmaceuticals Private Limited, with revenue of ₹5.84 Cr (FY 2025).
Rajamanikkam Kandasamy currently holds positions at 1 company: Biofloris Pharmaceuticals Private Limited (₹5.84 Cr).